Company profile
Personalised Diagnostics Limited
Home - PD2X
Personalised Diagnostics Limited is a UK company with status active founded in 2021 based in Yorkshire and the Humber.
Corporate ownership
Updated 06 Jun 2026 16:52
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Capital Allotment Shares
CapitalSH01 | Transaction MzQ0MjUzNzg1NGFkaXF6a2N4
Published 12 Nov 2024 04:49
Capital Allotment Shares
CapitalSH01 | Transaction MzQ0MTk1NjQ2NmFkaXF6a2N4
Published 04 Nov 2024 11:33
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzQ0MDc5ODE4MmFkaXF6a2N4
Published 25 Oct 2024 06:35
Change To A Person With Significant Control
Persons-with-significant-controlPSC04 | Transaction MzQ0MDc5ODE4NGFkaXF6a2N4
Published 24 Oct 2024 07:12
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzQ0MDc5Nzc5NmFkaXF6a2N4
Published 24 Oct 2024 07:12
Capital Allotment Shares
CapitalSH01 | Transaction MzQ0MDExOTA2N2FkaXF6a2N4
Published 18 Oct 2024 11:33
Capital Variation Of Rights Attached To Shares
CapitalSH10 | Transaction MzQzNTYxMDk0N2FkaXF6a2N4 | Paper/PDF filed
Published 14 Sep 2024 06:58
Capital Name Of Class Of Shares
CapitalSH08 | Transaction MzQzNTYxMjA3NmFkaXF6a2N4 | Paper/PDF filed
Published 14 Sep 2024 06:39
Accounts With Accounts Type Unaudited Abridged
Accounts AnalysedAA | Transaction MzQzNDY1NjA1NGFkaXF6a2N4
Published 05 Sep 2024 15:08
Capital Allotment Shares
CapitalSH01 | Transaction MzQzMjU0MjcxOWFkaXF6a2N4
Published 17 Aug 2024 00:34
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Development of Ultrafast Gold-Standard Pen-side Diagnostic for Pathogen and Antimicrobial Resistance Identification in Bovine Mastitis using plasmonic PCR
1 May 2024 to 31 Mar 2026
Bovine mastitis is a significant financial burden, substantially impacting milk production and the global dairy sector. The prevalent diagnostic techniques for mastitis are not only time-intensive but also lack the capability to ascertain antimicrobial resistance (AMR). Existing pen-side tests, while convenient, suffer from limitations in sensitivity and ...